BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 32522503)

  • 1. Sensory aspects of acceptability of bitter-flavoured 7.5 mm film-coated tablets in adults, preschool and school children.
    Hofmanová JK; Mason J; Batchelor HK
    Int J Pharm; 2020 Jul; 585():119511. PubMed ID: 32522503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developing methodology to evaluate the oral sensory features of pharmaceutical tablet coatings.
    Hofmanová JK; Rajabi-Siahboomi A; Haque S; Mason J; Teckoe J; To D; Batchelor HK
    Int J Pharm; 2019 May; 562():212-217. PubMed ID: 30910634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and evaluation of age-appropriate film-coated tablets of levamisole for paediatric use (2 - 18 years).
    Kreeftmeijer-Vegter AR; de Meijer M; Wegman KA; van Veldhuizen CK
    Expert Opin Drug Deliv; 2013 Mar; 10(3):293-300. PubMed ID: 23289762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence of acceptability of oral paediatric medicines: a review.
    Mistry P; Batchelor H;
    J Pharm Pharmacol; 2017 Apr; 69(4):361-376. PubMed ID: 27524471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized cross-over study to evaluate the swallow-enhancing and taste-masking properties of a novel coating for oral tablets.
    Uloza V; Uloziene I; Gradauskiene E
    Pharm World Sci; 2010 Aug; 32(4):420-3. PubMed ID: 20524068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can children swallow tablets? Outcome data from a feasibility study to assess the acceptability of different-sized placebo tablets in children (creating acceptable tablets (CAT)).
    Bracken L; McDonough E; Ashleigh S; Wilson F; Shakeshaft J; Ohia U; Mistry P; Jones H; Kanji N; Liu F; Peak M
    BMJ Open; 2020 Oct; 10(10):e036508. PubMed ID: 33039988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Taste assessment for paediatric drug Development: A comparison of bitterness taste aversion in children versus Naïve and expert young adult assessors.
    Ranmal SR; Nhouchi Z; Keeley A; Adler L; Lavarde M; Pensé-Lhéritier AM; Tuleu C
    Int J Pharm; 2023 Nov; 647():123494. PubMed ID: 37806503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The bad taste of medicines: overview of basic research on bitter taste.
    Mennella JA; Spector AC; Reed DR; Coldwell SE
    Clin Ther; 2013 Aug; 35(8):1225-46. PubMed ID: 23886820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Taste-masked quinine sulphate pellets: bio-availability in adults and steady-state plasma concentrations in children with uncomplicated Plasmodium falciparum malaria.
    Kayumba PC; Twagirumukiza M; Huyghebaert N; Ntawukuliryayo JD; van Bortel L; Vervaet C; Remon JP
    Ann Trop Paediatr; 2008 Jun; 28(2):103-9. PubMed ID: 18510819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing Palatability of a New Amphetamine Extended-Release Tablet Formulation for the Treatment of ADHD.
    Pardo A; King TR; Rafla E; Kando JC
    Drug Des Devel Ther; 2021; 15():2979-2985. PubMed ID: 34262263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensory attributes of coated tablets: Developing a formal lexicon and sensory wheel.
    Hofmanová JK; Mason J; Batchelor HK
    Int J Pharm; 2020 Nov; 590():119883. PubMed ID: 32946978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tribology provides an in vitro tool that correlated to in vivo sensory data on the mouthfeel of coated tablets.
    Hofmanová JK; Mason J; Batchelor HK
    Int J Pharm; 2021 Mar; 597():120323. PubMed ID: 33540034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of oral acetaminophen chewable tablets with inhibited bitter taste.
    Suzuki H; Onishi H; Takahashi Y; Iwata M; Machida Y
    Int J Pharm; 2003 Jan; 251(1-2):123-32. PubMed ID: 12527182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Taste-masked quinine pamoate tablets for treatment of children with uncomplicated Plasmodium falciparum malaria.
    Kayitare E; Vervaet C; Mehuys E; Kayumba PC; Ntawukulilyayo JD; Karema C; Bortel V; Remon JP
    Int J Pharm; 2010 Jun; 392(1-2):29-34. PubMed ID: 20230885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Creating Acceptable Tablets 3D (CAT 3D): A Feasibility Study to Evaluate the Acceptability of 3D Printed Tablets in Children and Young People.
    Bracken L; Habashy R; McDonough E; Wilson F; Shakeshaft J; Ohia U; Garcia-Sorribes T; Isreb A; Alhnan MA; Peak M
    Pharmaceutics; 2022 Feb; 14(3):. PubMed ID: 35335892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing oral medications for children.
    Mennella JA; Beauchamp GK
    Clin Ther; 2008 Nov; 30(11):2120-32. PubMed ID: 19108800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the Acceptability, Swallowability, and Palatability of Film-Coated Mini-Tablet Formulation in Young Children: Results from an Open-Label, Single-Dose, Cross-Over Study.
    Münch J; Sessler I; Bosse HM; Wargenau M; Dreesen JD; Loforese G; Webb NJA; Sivasubramanian R; Reidemeister S; Lustenberger P; Klingmann V
    Pharmaceutics; 2023 Jun; 15(6):. PubMed ID: 37376177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Responsive Sensory Evaluation to Develop Flexible Taste-Masked Paediatric Primaquine Tablets against Malaria for Low-Resource Settings.
    Ranmal SR; Lavarde M; Wallon E; Issa S; Taylor WR; Nguyen Ngoc Pouplin JLA; Tuleu C; Pensé-Lhéritier AM
    Pharmaceutics; 2023 Jul; 15(7):. PubMed ID: 37514065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acceptability, Swallowability, Palatability, and Safety of Multiple Film-Coated Mini-Tablets in Children Aged ≥2-<7 Years: Results of an Open-Label Randomised Study.
    Münch J; Kloft C; Farhan M; Fishman V; Leng S; Bosse HM; Klingmann V
    Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36840023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo investigation of taste-masking effectiveness of Eudragit E PO as drug particle coating agent in orally disintegrating tablets.
    Drašković M; Medarević D; Aleksić I; Parojčić J
    Drug Dev Ind Pharm; 2017 May; 43(5):723-731. PubMed ID: 27494420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.